RVL Pharmaceuticals plc·4

May 22, 9:18 PM ET

Klein Christopher 4

4 · RVL Pharmaceuticals plc · Filed May 22, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Klein Christopher
General Counsel and Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2023-05-18$0.87/sh5,447$4,739180,573 total

Documents

1 file
  • 4
    tm2316485d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT